• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
    • Examining Transportation
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • America at 250
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
    • Examining Transportation
  • Newsletters
More
    Advertisement
    Home › Tags › Posts tagged Pfizer

    Tag: Pfizer

    AstraZeneca rejects $119 billion offer from Pfizer Business

    AstraZeneca rejects $119 billion offer from Pfizer

    Washington Examiner · May 19, 2014 4:14 pm
    Pfizer raises offer, highlighting flurry of deals Business

    Pfizer raises offer, highlighting flurry of deals

    The Associated Press · May 19, 2014 8:25 am
    Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer Business

    Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer

    Washington Examiner · May 19, 2014 6:46 am
    Pfizer ups offer for AstraZeneca again, to $119B Business

    Pfizer ups offer for AstraZeneca again, to $119B

    Linda Johnson · May 19, 2014 4:06 am
    Advertisement
    Pfizer chief says jobs will go in takeover Business

    Pfizer chief says jobs will go in takeover

    Danica Kirka · May 13, 2014 3:44 pm
    AstraZeneca rejects sweetened Pfizer takeover bid Business

    AstraZeneca rejects sweetened Pfizer takeover bid

    DANICA KIRKALINDA A. JOHNSON · May 2, 2014 9:34 pm
    AstraZeneca board rejects sweetened takeover offer from Pfizer Business

    AstraZeneca board rejects sweetened takeover offer from Pfizer

    Washington Examiner · May 2, 2014 9:56 am
    Pfizer still pursuing AstraZeneca after 2nd rebuff Business

    Pfizer still pursuing AstraZeneca after 2nd rebuff

    DANICA KIRKALINDA A. JOHNSON · April 28, 2014 6:59 pm
    Advertisement
    AstraZeneca shares soar on Pfizer interest Business

    AstraZeneca shares soar on Pfizer interest

    Danica Kirka · April 28, 2014 11:16 am
    Pfizer still wants AstraZeneca after $98.7 billion bid rejected Healthcare

    Pfizer still wants AstraZeneca after $98.7 billion bid rejected

    oliver-staley, phil-serafino · April 28, 2014 4:00 am
    Pfizer to help investors with dividend, buybacks Business

    Pfizer to help investors with dividend, buybacks

    The Associated Press · April 24, 2014 9:08 pm
    FDA official: Agency is committed to timely approval of vaccines Healthcare

    FDA official: Agency is committed to timely approval of vaccines

    karen-midthun · April 18, 2014 4:00 am
    Advertisement
    • ‹Previous page
    • 1
    • …
    • 27
    • 28
    • 29
    • 30
    • ›Next page
    Page 29 of 30
    Advertisement
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.